An update to the PrEvENT trial in England

The Prostate Cancer: Evidence of Exercise and Nutrition Trial (PrEvENT) has been ongoing in England since August 2014 and is an important and serious exploration of how diet and exercise may affect the outcomes of men who are treated for prostate cancer. … READ MORE …

STAMPEDE group to present abiraterone survival data at ASCO too

We have just heard from the STAMPEDE trial group in the UK that they will be presenting overall survival data from the “abiraterone comparison” arm of the STAMPEDE trial at the upcoming ASCO meeting this year. … READ MORE …

Data from the LATITUDE trial to be presented at ASCO

According to an e-mail your sitemaster has just received from ASCO, we will be getting the initial results from the LATITUDE trial at the upcoming ASCO meeting in June this year. … READ MORE …

A thorough review of immunotherapeutics in the treatment of prostate cancer

A new review article has just been published in the journal Critical Reviews in Hematology Oncology. It is probably a current “must read” for support group leaders and for any patients who are interested in the idea of using immunotherapy as a treatment for progressive and advanced forms of prostate cancer. … READ MORE …

The benefits of yoga for prostate cancer patients undergoing radiotherapy

A small, but randomized Phase II clinical trial has shown benefits of structured yoga classes for men receiving radiation therapy for the treatment of prostate cancer. … READ MORE …

ASCO issues new PCO in treatment of chemotherapy-naive CRPC

ASCO has just released a new set of provisional guidance (a “provisional clinical opinion” or PCO) on the second-line treatment of men with chemotherapy-naive, castration-resistant prostate cancer (CRPC), i.e., men who are progressing on initial androgen deprivation therapy (ADT or “hormone” therapy) but who haven’t had docetaxel-based chemotherapy yet. … READ MORE …

Listen to Dr. Schellhammer discussing “Living well with prostate cancer”

Yesterday evening we were able to spend an hour talking with Dr. Paul Schellhammer — a prostate cancer patient and also a widely recognized prostate cancer specialist — about issues related to quality of life  and “living well” after diagnosis and treatment for prostate cancer over time. The recording of this conversation is now available on line on the CureTalks web site. … READ MORE …